Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33 GBX | +1.54% | +8.20% | +24.53% |
05-08 | Home REIT cuts borrowings, Genflow shares restored | AN |
03-26 | EARNINGS: CAB Payments profit drops, Life Science REIT cuts dividend | AN |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 25.02 | 18.61 | 12.34 | 10.8 | 11.57 | 10.22 |
Enterprise Value (EV) 1 | 22.8 | 17.59 | 9.933 | 8.947 | 8.736 | 6.793 |
P/E ratio | 12.5 x | 11.3 x | 32.1 x | 10.4 x | 8.94 x | 13.3 x |
Yield | 6.2% | 1.78% | - | 1.43% | 1.67% | 2.08% |
Capitalization / Revenue | 1.3 x | 0.97 x | 0.85 x | 0.68 x | 0.63 x | 0.48 x |
EV / Revenue | 1.18 x | 0.92 x | 0.68 x | 0.56 x | 0.47 x | 0.32 x |
EV / EBITDA | 7.27 x | 7.83 x | 15.6 x | 7.47 x | 4.8 x | 3.65 x |
EV / FCF | 10.2 x | 9.57 x | 7.22 x | -12.2 x | 14.7 x | 37.5 x |
FCF Yield | 9.79% | 10.4% | 13.8% | -8.2% | 6.83% | 2.67% |
Price to Book | 1.85 x | 1.25 x | 0.88 x | 0.66 x | 0.7 x | 0.68 x |
Nbr of stocks (in thousands) | 41,354 | 41,354 | 38,577 | 38,577 | 38,577 | 38,577 |
Reference price 2 | 0.6050 | 0.4500 | 0.3200 | 0.2800 | 0.3000 | 0.2650 |
Announcement Date | 06/03/19 | 04/03/20 | 03/03/21 | 12/04/22 | 05/04/23 | 27/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 19.26 | 19.18 | 14.55 | 15.86 | 18.48 | 21.1 |
EBITDA 1 | 3.134 | 2.246 | 0.638 | 1.198 | 1.821 | 1.863 |
EBIT 1 | 2.704 | 1.975 | 0.372 | 0.892 | 1.483 | 1.456 |
Operating Margin | 14.04% | 10.3% | 2.56% | 5.62% | 8.02% | 6.9% |
Earnings before Tax (EBT) 1 | 2.612 | 1.961 | 0.5 | 1.291 | 1.433 | 1.413 |
Net income 1 | 2.008 | 1.558 | 0.391 | 1.042 | 1.295 | 0.769 |
Net margin | 10.43% | 8.12% | 2.69% | 6.57% | 7.01% | 3.64% |
EPS 2 | 0.0486 | 0.0397 | 0.009956 | 0.0270 | 0.0336 | 0.0199 |
Free Cash Flow 1 | 2.232 | 1.838 | 1.376 | -0.7339 | 0.5962 | 0.1814 |
FCF margin | 11.59% | 9.58% | 9.45% | -4.63% | 3.23% | 0.86% |
FCF Conversion (EBITDA) | 71.23% | 81.83% | 215.6% | - | 32.74% | 9.74% |
FCF Conversion (Net income) | 111.17% | 117.97% | 351.79% | - | 46.04% | 23.59% |
Dividend per Share 2 | 0.0375 | 0.008000 | - | 0.004000 | 0.005000 | 0.005500 |
Announcement Date | 06/03/19 | 04/03/20 | 03/03/21 | 12/04/22 | 05/04/23 | 27/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 2.22 | 1.02 | 2.41 | 1.85 | 2.84 | 3.43 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 2.23 | 1.84 | 1.38 | -0.73 | 0.6 | 0.18 |
ROE (net income / shareholders' equity) | 23.5% | 11.4% | 2.8% | 6.85% | 7.88% | 4.9% |
ROA (Net income/ Total Assets) | 7.61% | 5.82% | 1.05% | 2.29% | 3.71% | 3.46% |
Assets 1 | 26.39 | 26.76 | 37.36 | 45.49 | 34.88 | 22.24 |
Book Value Per Share 2 | 0.3300 | 0.3600 | 0.3600 | 0.4300 | 0.4300 | 0.3900 |
Cash Flow per Share 2 | 0.0700 | 0.0800 | 0.1700 | 0.1500 | 0.1500 | 0.1500 |
Capex 1 | 0.4 | 0.38 | 0.23 | 1.24 | 0.31 | 1.17 |
Capex / Sales | 2.07% | 1.97% | 1.6% | 7.79% | 1.69% | 5.53% |
Announcement Date | 06/03/19 | 04/03/20 | 03/03/21 | 12/04/22 | 05/04/23 | 27/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+24.53% | 15.73M | |
-1.84% | 3.12B | |
+26.39% | 945M | |
+3.72% | 369M | |
+12.60% | 266M | |
+1.94% | 169M | |
+19.10% | 142M | |
0.00% | 121M | |
-60.16% | 105M | |
-10.25% | 64.38M |
- Stock Market
- Equities
- AIEA Stock
- Financials AIREA plc